Dennis Yurichev’s blog
-
1
[Crypto] Communicating with TPM 2.0: the first step
-
2
[Crypto] Time-based one-time password (TOTP) for 2FA, part II: YubiKey
-
3
Time-based one-time password (TOTP) for 2FA, part I
-
4
Unpacking a database of unknown type
-
5
Amateur cryptography: decrypting TVT CCTV camera config files
-
6
Making C compiler generate obfuscated code
-
7
Tweaking LLVM Obfuscator + quick look into some of LLVM internals
-
8
Fuzzy string matching + simplest possible spellchecking + hunting for typos and misspellings in Wikipedia
-
9
Typeless programming languages (BCPL, B), C evolution and decompiling
-
10
Content-addressable storage
Download 2D Unlock APKs for Android – APKMirror
-
1
HUAWEI Browser 17.0.7.302 by HUAWEI
-
2
HUAWEI Browser 17.0.8.300 by HUAWEI
-
3
HUAWEI Browser 17.0.8.310 by HUAWEI
-
4
HUAWEI AppGallery 16.7.1.300 by HUAWEI
-
5
HUAWEI Browser 17.0.6.313 by HUAWEI
-
6
HUAWEI AppGallery 16.6.1.300 by HUAWEI
-
7
HwPanPayService 14.3.1.300 by HUAWEI
-
8
Messaging 14.5.1.104 by HUAWEI
-
9
Service Center 23.1.5.341 by HUAWEI
-
10
HUAWEI Quick App Center 16.4.1.301 by HUAWEI
eClinicalMedicine
-
1
[Articles] A multimodal digital NeuroMarker platform with composite and domain-level validity for identification of mild cognitive impairment: a cross-sectional study
-
2
[Articles] The effects of the arts and arts therapies on mental health outcomes of children and young people: a systematic review and meta-analysis
-
3
[Articles] Generalisability of an adult-trained AI model to paediatric coeliac disease diagnosis: a multicentre external validation study
-
4
[Articles] Efficacy and safety of temporary selective portal vein embolization before major hepatectomy (EMBORES): a phase 2 trial
-
5
[Viewpoint] Relative risk reduction is not enough: why cardiorenal trials should routinely report absolute risk reduction and number needed to treat
-
6
[Articles] Weight loss and blood pressure lowering with GLP-1 receptor agonists and multi-hormone receptor modulators in overweight and obesity: a systematic review and meta-regression of phase 3 clinical trials
-
7
[Articles] Neighborhood disadvantages and longitudinal progression of multimorbidity among adult survivors of childhood cancer: a single-center St. Jude Lifetime Cohort Study in the U.S.
-
8
[Corrigendum] Corrigendum to “A methodology for determining dosing recommendations for anticancer drugs in patients with reduced kidney function”
-
9
[Review] Systematized scoping review of instruments for measuring adolescent digital technology use
-
10
[Review] Sex work or male-with-male sexual activity and the risks of HIV and hepatitis C acquisition among people who inject drugs: a global systematic review and meta-analysis
The Lancet
-
1
[Obituary] Khairul Islam
-
2
[Correspondence] Nephromegaly-driven malnutrition in autosomal dominant polycystic kidney disease
-
3
[Perspectives] A guide to anti-racist medicine
-
4
[Correspondence] Communication: the missing pillar of clinical trial governance
-
5
[Department of Error] Department of Error
-
6
[Correspondence] Unanswered questions from the NIMBLE trial – Authors’ reply
-
7
[Articles] Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial
-
8
[World Report] Warnings over Ukraine maternity care
-
9
[Comment] Offline: Berlin diary
-
10
[Department of Error] Department of Error
The Lancet Child & Adolescent Health
-
1
[Editorial] Clean air is lung care
-
2
[Articles] Global reference values for daily steps in preschool children (SUNRISE): a cross-sectional analysis from 44 countries
-
3
[Articles] Immunogenicity up to age 5 years following a single-dose or two-dose infant primary series of 10-valent or 13-valent pneumococcal conjugate vaccine each followed by a booster dose in South Africa: extended follow-up of a single-centre, open-lab
-
4
[Articles] Injury burden among adolescents and young adults aged 10–24 years in the Arab region, 1990–2023: a systematic analysis of the Global Burden of Disease Study 2023
-
5
[Comment] An injury burden crisis among young people in the Arab region
-
6
[Comment] An urgent opportunity to ensure children's access to oral post-exposure prophylaxis trials for Bundibugyo virus disease
-
7
[Articles] Comparative effectiveness of clarithromycin and azithromycin for pertussis in hospitalised infants in Italy: a multicentre target trial emulation study
-
8
[Review] Methylation profile scores in child and adolescent health: a practical guide
-
9
[Health Policy] A global policy content analysis of congenital heart disease in national health priorities
-
10
[Comment] Prioritising pregnant and parenting adolescents in the HIV and SRHR response
The Lancet Diabetes & Endocrinology
-
1
[Comment] Precision medicine in type 2 diabetes: should clustering be used?
-
2
[Correspondence] Bone mineral density as a surrogate endpoint in osteoporosis trials – Author's reply
-
3
[Correspondence] Bone mineral density as a surrogate endpoint in osteoporosis trials
-
4
[Comment] What Mauritius teaches us about diabetes surveillance
-
5
[Articles] Trends in prevalence of type 2 diabetes and intermediate hyperglycaemia in Mauritius from 1987 to 2021 based on results from the oral glucose tolerance test: a repeated cross-sectional study
-
6
[Editorial] Safeguarding paediatric metabolic health
-
7
[Personal View] Disease modification outcomes in type 2 diabetes: a modified Delphi
-
8
[Comment] Petrelintide and the evolving role of amylin agonism in obesity
-
9
[Articles] Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trial
-
10
[Corrections] Correction to Lancet Diabetes Endocrinol 2026; 14: 149–56
The Lancet Digital Health
-
1
[Editorial] Epilepsy research in the AI era
-
2
[Articles] Effect of a computer-aided quality feedback system on colonoscopists’ adenoma detection rate in Denmark: a multicentre, stepped-wedge, cluster-randomised, controlled trial
-
3
[Review] Artificial intelligence models for automated and semiautomated analysis and interpretation of clinical electroencephalography
-
4
[Review] Machine learning prediction for epilepsy treatment selection and prognosis: achievements and challenges
-
5
[Articles] Status, challenges, and future directions of machine learning in the management of epilepsy: a systematic review and meta-analysis
-
6
[Articles] Multimodal artificial intelligence-based long-term mortality prediction after transcatheter aortic valve implantation: a multicentre development, validation, and testing study
-
7
[Articles] Performance and label efficiency of traditional deep-learning models and a retina-specific foundation model for ocular and systemic disease detection: a retrospective comparative study
-
8
[Comment] Power, governance, and accountability in humanitarian artificial intelligence
-
9
[Comment] Need for ethical use of artificial intelligence in humanitarian data collection to address aid shortfalls
-
10
[Articles] Toward unified and comprehensive automated electroencephalogram interpretation: a multicentre development and validation of an electroencephalogram foundation model
The Lancet Gastroenterology & Hepatology
-
1
[Corrections] Correction to Lancet Gastroenterol Hepatol 2025; 10: 537–49
-
2
[News] Research in Brief
-
3
[Editorial] Baveno VIII: what's new?
-
4
[Correspondence] Validation of Rome V for irritable bowel syndrome
-
5
[Correspondence] Tackling the global liver disease syndemic through primary care in the Asia-Pacific region
-
6
[Correspondence] Adjuvant chemoradiotherapy or completion total mesorectal excision after local excision of rectal cancer
-
7
[Correspondence] Adjuvant chemoradiotherapy or completion total mesorectal excision after local excision of rectal cancer
-
8
[Correspondence] Adjuvant chemoradiotherapy or completion total mesorectal excision after local excision of rectal cancer
-
9
[Correspondence] Lessons from the TRIPLET-HCC trial
-
10
[Correspondence] Adjuvant chemoradiotherapy or completion total mesorectal excision after local excision of rectal cancer – Authors’ reply